IP Library Granted Patent US 8,114,856
Granted Patent B2
US 8,114,856 · App. 12/987,842 · Granted Feb 14, 2012

Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,856
App. No.
12/987,842
Granted
Feb 14, 2012
Kind
B2
Abstract

The present invention is directed to analogs of aminoglycoside compounds as well as their preparation and use as prophylactic or therapeutics against microbial infection.

Claims (46)

1. A compound having the following formula VI:

or a prodrug or pharmaceutically acceptable salt thereof,

wherein:

Q1 is —NR 10 R 11 ;

Q 2 is

each Q 3 and Q 4 is —OR 7 ;

Q 5 is —OR 8 ;

each of R 1 , R 6 , R 7 and R 8 is, in each instance, H;

each R 2 and R 10 is, independently, H, C 1 -C 12 alkyl or substituted C 1 -C 12 alkyl;

R 11 is cyano, C 1 -C 12 alkyl, substituted C 1 -C 12 alkyl, C 2 -C 12 alkenyl, substituted C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, substituted C 2 -C 12 alkynyl or —(CH 2 ) n -(L 1 ) m -(CH 2 ) nn -E 1 ;

L 1 is S, O or NJ 1 ;

n is an integer from 1 to 8;

m is 0 or 1;

nn is 0 or an integer from 1 to 8;

mm is 1 or 2;

E 1 is H, hydroxyl, halogen, cyano, —NJ 1 J 2 , C 2 -C 12 alkenyl, substituted C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, substituted C 2 -C 12 alkynyl, C 5 -C 20 aryl, substituted C 5 -C 20 aryl, heteroaryl, substituted heteroaryl, a heterocyclic radical, a substituted heterocyclic radical or a substituted or unsubstituted mono or poly cyclic structure that is unsaturated, partially saturated or fully saturated and optionally includes one or more heteroatoms selected from O, N and S;

each J 1 and J 2 is, independently, H, C 1 -C 12 alkyl, substituted C 1 -C 12 alkyl, C 2 -C 12 alkenyl, substituted C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, substituted C 2 -C 12 alkynyl, C 5 -C 20 aryl, substituted C 5 -C 20 aryl, —C(═O)—X, a heterocyclic radical or a substituted heterocyclic radical;

each X is, independently, H, C 1 -C 12 alkyl or substituted C 1 -C 12 alkyl; and

Z 1 and Z 2 are each, independently, H or —OH.

2. A compound according to claim 1 , wherein mm is 1.

3. A compound according to claim 1 , wherein mm is 2.

4. A compound according to claim 1 , wherein each R 2 is H.

5. A compound according to claim 1 , wherein Z 1 is —OH.

6. A compound according to claim 1 , wherein R 10 is H.

7. A compound according to claim 6 , wherein R 11 is substituted C 1 -C 12 alkyl.

8. A compound according to claim 1 , wherein:

R 10 is H;

R 11 is substituted C 1 -C 12 alkyl;

each R 2 is H; and

Z 1 is —OH.

9. A compound according to claim 8 , wherein mm is 1.

10. A compound according to claim 8 , wherein mm is 2.

11. A compound according to claim 1 having the configuration:

12. A compound according to claim 11 , wherein mm is 1.

13. A compound according to claim 11 , wherein mm is 2.

14. A compound according to claim 11 , wherein each R 2 is H.

15. A compound according to claim 11 , wherein Z 1 is —OH.

16. A compound according to claim 11 , wherein R 10 is H.

17. A compound according to claim 16 , wherein R 11 is substituted C 1 -C 12 alkyl.

18. A compound according to claim 11 , wherein:

R 10 is H;

R 11 is substituted C 1 -C 12 alkyl;

each R 2 is H; and

Z 1 is —OH.

19. A compound according to claim 18 , wherein mm is 1.

20. A compound according to claim 18 , wherein mm is 2.

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 19, 2019
From: ACHAOGEN, INC.
To: SILICON VALLEY BANK
Reel/Frame 048947/0702 →
CHANGE OF NAME Recorded Jun 28, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043029/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2011
From: SWAYZE, ERIC E.; HANESSIAN, STEPHEN; SZYCHOWSKI, JANEK; ADHIKARI, SUSANTA SEKHAR; PACHAMUTHU, KANDASAMY; WANG, XIAOJING; MIGAWA, MICHAEL T.; GRIFFEY, RICHARD H.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 026018/0447 →